Orthovita to launch bone void filler in Europe:
This article was originally published in Clinica
Executive Summary
Orthovita has CE-marked for sale in Europe its synthetic cancellous bone void filler for filling bony gaps in the skeletal system. The Vitoss Scaffold, a resorbable calcium phosphate, is delivered as a pre-formed scaffold matrix that resembles the porosity of normal cancellous bone. The product is replaced as bone remodels. Malvern, Pennsylvania-based Orthovita said the scaffold marked the company's first product entry into the orthopaedic spine and trauma bone substitute markets. It will launch the product in Europe in September and has submitted it to the FDA for US market clearance.